Journal Home > Volume 2 , Issue 1
Brain Science Advances 2016, 2(1): 1-2 https://doi.org/10.18679/CN11-6030_R.2016.002
Editorial | Open Access | Issue | Published: 01 March 2016

Biomarkers in Alzheimer’s disease

Show Author's Information Rajka M. Liscic1,2,  Yuanhan Yang3,4,5( )
Clinic for Neurology, RHÖN Clinics, Campus Bad Neustadt, Bad Neustadt, Germany
Department of Anatomy and Neuroscience, School of Medicine, University of Osijek, Osijek, Croatia
Department of Neurology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, China
Department of Master’s Program in Neurology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, China
Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, China
Keywords:
Alzheimer’s disease, biomarker
Cite this article:
Liscic RM, Yang Y. Biomarkers in Alzheimer’s disease. Brain Science Advances, 2016, 2(1): 1-2. https://doi.org/10.18679/CN11-6030_R.2016.002
Download citation
EndNote(RIS)
BibTeX

267

Views

9

Downloads

Citations

1

Crossref

N/A

WoS

N/A

Scopus

N/A

CSCD

Abstract Full text About this article

Alzheimer’s disease (AD) so far did not have promising treatment. The accurate and early diagnosis is still the important issue. For these purpose, biomarkers related to diagnosis, clinical course, and other aims have been proposed and reported. Meanwhile, along with the ongoing researches for AD, biomarkers with their own aims are also on the way.


menu
Abstract
Full text
Outline
About this article

Biomarkers in Alzheimer’s disease

Show Author's information Rajka M. Liscic1,2, Yuanhan Yang3,4,5( )
Clinic for Neurology, RHÖN Clinics, Campus Bad Neustadt, Bad Neustadt, Germany
Department of Anatomy and Neuroscience, School of Medicine, University of Osijek, Osijek, Croatia
Department of Neurology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, China
Department of Master’s Program in Neurology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, China
Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, China

Abstract

Alzheimer’s disease (AD) so far did not have promising treatment. The accurate and early diagnosis is still the important issue. For these purpose, biomarkers related to diagnosis, clinical course, and other aims have been proposed and reported. Meanwhile, along with the ongoing researches for AD, biomarkers with their own aims are also on the way.

Keywords: Alzheimer’s disease, biomarker

References(5)

[1]
Lee Y. The recent decline in prevalence of dementia in developed countries: Implications for prevention in the Republic of Korea. J Korean Med Sci 2014, 29(7): 913–918.
DOI Google Scholar
[2]
Lublin AL, Gandy S. Amyloid-beta oligomers: Possible roles as key neurotoxins in Alzheimer's disease. Mt Sinai J Med 2010, 77(1): 43–49.
DOI Google Scholar
[3]
Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 1992, 89(12): 5462–5466.
DOI Google Scholar
[4]
Lee HJ, Zhang Y, Zhu C, Duff K, Pardridge WM. Imaging brain amyloid of Alzheimer disease in vivo in transgenic mice with an Abeta peptide radiopharmaceutical. J Cereb Blood Flow Metab 2002, 22(2): 223–231.
DOI Google Scholar
[5]
Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, O'Keefe G, Ackerman U, Tochon-Danguy H, Chan JG, Reininger CB, Fels L, Putz B, Rohde B, Masters CL, Rowe CC. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J Nucl Med 2011, 52(8): 1210–1217.
DOI Google Scholar
Publication history
Copyright
Rights and permissions

Publication history

Received: 09 December 2015
Revised: 28 January 2016
Accepted: 29 January 2016
Published: 01 March 2016
Issue date: March 2016

Copyright

© The authors 2016.

Rights and permissions

This article is published with open access at www.TNCjournal.com

Return